Skip to main content

cholestyramine

Generic: CHOLESTYRAMINE·Brand: CHOLESTYRAMINE, CHOLESTYRAMINE LIGHT, CHOLYBAR, LOCHOLEST, LOCHOLEST LIGHT, PREVALITE, QUESTRAN, QUESTRAN LIGHT

cholestyramine: 2 clinical trials tracked.

cholestyramine evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about cholestyramine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Multiple Sclerosis
Clinical Trials (2)

Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis

NCT06141473·Phase 3·SNY
Active, not recruiting

Primary endpoint: Annualized relapse rate (ARR) during the study period assessed by protocol defined adjudicated relapses

InterventionalRandomizedquadruple1,655 enrolledStarted 2023-12Completion 2027-0550 sites · United StatesSanofi

Pilot Trial of Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

NCT05443425·Phase 1
Recruiting

Primary endpoint: Incidence of adverse events

Interventionalopen18 targetStarted 2023-06Completion 2027-011 site · United StatesCity of Hope Medical Center